Company Filing History:
Years Active: 1997
Title: Heinrich Terlau: Innovator in Metabolic Disease Research
Introduction
Heinrich Terlau is an inventor based in Eckernforde, Germany. He has made significant contributions to the field of metabolic diseases through his innovative research. His work focuses on the modulation of glucose-induced insulin secretion, which is crucial for managing metabolic conditions.
Latest Patent Applications
Heinrich Terlau's notable patent application is titled "USE OF CONKUNITZIN-S1 FOR THE MODULATION OF GLUCOSE-INDUCED INSULIN SECRETION." This application describes a (poly)peptide or a peptidomimetic that exhibits the biological activity of Conkunitzin-S1. The invention includes a polypeptide with a specific amino acid sequence or one that has at least 85% sequence identity to a defined sequence. The application outlines methods for screening (poly)peptides derived from Conkunitzin-S1 that can modulate the activity of a Kv1.7 containing channel, which is relevant for treating or preventing metabolic diseases.
Conclusion
Heinrich Terlau's innovative work in the modulation of insulin secretion highlights the potential for new treatments in metabolic diseases. His research may pave the way for future advancements in this critical area of health.